Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: The role of DNA methylation in the transcriptional regulation of S100A4 is unknown in human prostate cancer. METHODS: Critical CpG sites within intron 1 of S100A4 were sequenced in DNA obtained from prostatic adenocarcinoma, non-malignant epithelium, and prostate cancer cell lines. S100A4 protein expression was assessed by immunohistochemistry and Western blotting. RESULTS: Methylation was seen in all cases of cancer, non-malignant epithelium, and in prostate cancer cell lines, but was absent in all cases of blood DNA. S100A4 immunoexpression was absent in all cases of malignant and non-malignant epithelium, while strong-moderate expression was seen in the stroma and lymphocytes. Western blotting showed absent S100A4 expression in LNCaP and Du145 cells and low levels in PC-3 cells. CONCLUSIONS: S100A4 protein is not expressed in benign or malignant prostatic epithelium nor in LNCaP and Du145 cells. The mechanism underlying absent S100A4 expression in prostatic epithelium and cell lines may involve methylation.

Original publication

DOI

10.1002/pros.20401

Type

Journal article

Journal

Prostate

Publication Date

01/03/2007

Volume

67

Pages

341 - 347

Keywords

Adenocarcinoma, Base Sequence, Blotting, Western, Calcium-Binding Proteins, Cell Line, Tumor, CpG Islands, DNA Methylation, Epithelium, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Molecular Sequence Data, Prostate, Prostatic Neoplasms, S100 Calcium-Binding Protein A4, S100 Proteins